Predict your next investment

Corporation
visiontravel.ca

See what CB Insights has to offer

Partners & Customers

5

About Vision Travel

Vision Travel specializes in travel management in Canada, providing a full range of corporate, meetings & incentives, leisure and loyalty travel services from coast to coast to a wide spectrum of Canadian companies.

Vision Travel Headquarter Location

251 Consumers Road Suite 700

Toronto, Ontario, M2J 1R3,

Canada

416-487-5385

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Vision Travel News

COVID-19 live updates: Announcement on border measure changes coming soon; Message shifts on airborne transmission; Alberta reports 321 new cases Tuesday

Nov 17, 2021

Author of the article: A man walks past an ad for travel to sunny destinations on Vision Travel's window on 108 Street in Edmonton, on Tuesday, Nov. 16, 2021. The Capital region has been hit by the first major snowstorm of the season. Photo by Ian Kucerak /Postmedia Article content COVID-19 news happens rapidly, we have created this file to keep you up-to-date on all the latest stories and information on the outbreak in and around Edmonton. Advertisement Article content Try refreshing your browser, or What’s happening now A heightened emphasis by the Public Health Agency of Canada that COVID-19 can spread through the air , like second-hand smoke, is seen as positive — but late. The federal government will announce changes to COVID-19 prevention measures at the Canadian border “very soon,” Health Minister Jean-Yves Duclos said Tuesday. At Tuesday’s COVID-19 update, Dr. Deena Hinshaw, Alberta’s chief medical officer of health, said increased indoor gatherings could cause a devastating spike in the province’s cases. NDP accuses Alberta government of ‘cowardice’ by avoiding debate on Kenney’s COVID-19 leadership . A study released from the University of Calgary this week shows that a drug used to treat critically ill COVID-19 patients has had little to no benefit for women Health Canada says it has received a submission from Moderna to authorize use of its COVID-19 vaccine for children aged six to 11. Germany recorded 32,048 new infections on Tuesday, a rise of 47% compared to a week ago, and another 265 deaths, bringing Germany’s total during the pandemic to 97,980. Starting Monday, Albertans entering businesses participating in the province’s vaccine passport program will need to show a QR code as proof of vaccination. Advertisement Article content Share your COVID-19 stories As Alberta grapples with a fourth wave of COVID-19 at the start of another school year, we’re looking to hear your stories on this evolving situation. Have you or a loved one had a surgery rescheduled or cancelled in recent weeks? Are you someone who has decided to get vaccinated after previously being skeptical of the vaccines? Have you changed your mind about sending your children back to school in person? Have you enrolled your children in a private school due to COVID-19? Are you a frontline health-care worker seeing new strains on the health system? Send us your stories via email at edm-feedback@postmedia.com Wednesday The Canadian Press Article content A car crosses the Canada-U.S border at the Thousand Islands crossing in Ontario after the border officially reopened for fully-vaccinated Canadian travellers on Monday Nov. 8. Photo by JESSICA MUNRO /Postmedia Network OTTAWA — The federal government will announce changes to COVID-19 prevention measures at the Canadian border “very soon,” Health Minister Jean-Yves Duclos said Tuesday. Article content The government has faced mounting pressure for weeks to do away with a requirement for fully vaccinated travellers into Canada to provide a negative molecular COVID-19 test. For travellers making only a short jaunt over the border, the test can be completed in Canada before the trip takes place — drawing even more ire from travellers and the tourism sector. The rule is part of an order-in-council that will expire on Sunday. Chief public health officer Dr. Theresa Tam has defended the test requirement in the past, saying it provides another layer of protection at the border and prevents travellers from unwittingly importing cases into Canada. Advertisement Article content But lately, she has indicated a change may be in the works. “That requirement is being actively reviewed, I’m sure there will be further information to come,” Tam said at a briefing Friday. Elizabeth Payne Chief Public Health Officer of Canada Dr. Theresa Tam wrote a series of tweets last weekend about airborne spread of the COVID-19 virus that advised Canadians to wear snug fitting masks that better protect against airborne transmission and to ventilate, among other things. Photo by Adrian Wyld /The Canadian Press Twenty-two months into the pandemic, there is something new in the air: a heightened emphasis by the Public Health Agency of Canada that COVID-19 can spread through the air, like second-hand smoke. Article content As far back as last November, PHAC quietly acknowledged that COVID-19 could be spread through the air and not just through droplets. But it offered little or no advice about what that would mean to the way people and institutions prevent transmission, critics say. Advertisement Article content On the frontlines in Ontario and elsewhere, evidence of airborne spread was often ignored, critics say, which meant health workers didn’t always get the level of protection they should have, among other things. That could begin to change with a message shift from PHAC. Clear statements from Chief Public Health Officer of Canada Dr. Theresa Tam and the public health agency in recent days are being welcomed by those who have long called for better action to prevent airborne spread of COVID-19 in Canada. Lisa Johnson NDP justice critic Irfan Sabir highlighted concerns from communities across the province over Bill 63: the Street Checks and Carding Amendment Act, April 20, 2021. Photo by NDP Supplied The Alberta NDP is accusing the government of “cowardice” after UCP MLAs used their majority to avoid debating a motion condemning Premier Jason Kenney’s leadership on COVID-19. Advertisement Article content The motion, calling for the formal censure of Kenney’s “failed leadership” before and during the fourth wave of the pandemic, was pushed to the bottom of the legislature’s order paper Monday night, increasing the likelihood it will die on the order paper without a vote when the session ends. On Tuesday, NDP MLA Irfan Sabir told reporters in the legislature it was a “shameful display of cowardice” by the government. “Instead of debating the motion, Jason Kenney and his UCP MLAs ran away,” said Sabir, who added the private member’s motion is about holding Kenney accountable for the crisis created in the health-care system, including 15,000 delayed surgeries. During question period Tuesday, NDP Leader Rachel Notley asked Kenney why members were not allowed to vote on his COVID-19 leadership record. Advertisement Article content Kenney countered that the house did vote — to defer the motion. “The NDP is desperate to continue trying to divide people on the basis of the pandemic rather than unite Albertans in enthusiasm for this economy,” said Kenney, who listed several recent major investments in the province. Dr. Deena Hinshaw, Alberta’s chief medical officer of health. Photo by Ian Kucerak /Postmedia As COVID-19 cases continue to be on the lower end of the fourth wave scale, Alberta’s top doctor says the incoming winter weather and holiday season could be cause for concern. At Tuesday’s COVID-19 update, Dr. Deena Hinshaw, Alberta’s chief medical officer of health, said increased indoor gatherings could cause a devastating spike in the province’s cases. “With the seasonality of the virus, people moving inside and having that increased risk in indoor settings, there is a risk that we could see a fifth wave,” Hinshaw said. Alberta reported 321 new cases of the virus on Tuesday with a test positivity of about 5.1 per cent. Albertans in hospital beds and intensive care units with COVID-19 did not see much of a change. There are now 518 people in hospital, one less than the previous day and there are 101 people in ICU, an increase of one patient from Monday’s numbers. There were an additional 13 deaths reported on Tuesday. Advertisement Article content Try refreshing your browser, or Stephanie Babych, Calgary Herald Teams in a crowded Calgary ICU work on a patient on a ventilator. Photo by supplied by AHS A study released from the University of Calgary this week shows that a drug used to treat critically ill COVID-19 patients has had little to no benefit for women, according to researchers. One of the main treatments for severe COVID-19 lung infections, dexamethasone, alters how immune cells work, and research into the way people’s immune system responds to COVID-19 shows that the sex of a patient might impact the effectiveness of certain drugs, including dexamethasone. The study found the drug may only be benefiting male patients. “We found that the males derived benefit from the steroids and the females, at both the cellular level and at the population level, received limited benefit,” said Dr. Bryan Yipp, associate professor with the Department of Critical Care Medicine at the University of Calgary’s Cumming School of Medicine. Advertisement Article content “Currently, it’s possible the mainstay therapy for severe COVID-19 that we’re giving everybody is only benefiting half the population. This is a big problem.” Yipp led the multidisciplinary study alongside Dr. Jeff Biernaskie, a professor of Comparative Biology and Experimental Medicine in the Faculty of Veterinary Medicine. When physicians and researchers were scrambling for effective treatment of COVID-19 at the start of the pandemic in 2020, steroids were first to be identified as a treatment that helped patients with severe illness. However, steroids were only moderately successful at reducing COVID deaths and it wasn’t clear how they were benefiting patients. The Canadian Press Article content This file photo taken on October 14, 2021 shows boxes containing vials of the Moderna Covid-19 vaccine stored at the Kedren Community Health Center in Los Angeles, California. Photo by PATRICK T. FALLON /AFP via Getty Images OTTAWA — Health Canada says it has received a submission from Moderna to authorize use of its COVID-19 vaccine for children aged six to 11. The agency says it will prioritize the review of the submission, while maintaining high scientific standards for safety, efficacy and quality. It says the assessment will consider clinical trial data and emerging research about the impacts of COVID-19 in children to determine if the benefits of the vaccine outweigh the risks in this age group. Health Canada is currently reviewing Pfizer-BioNTech’s submission for approval of its COVID-19 vaccine for children aged five to 11, and officials have indicated that a decision could come within the month. Reuters Article content A syringe and vial are seen in front of a displayed Pfizer logo in this illustration PHOTO taken June 24, 2021. Photo by Dado Ruvic / Illustration /REUTERS / FILES Pfizer Inc said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). The voluntary licensing agreement between Pfizer and the MPP will allow the UN-backed group to grant sub-licenses to qualified generic drug manufacturers to make their own versions of PF-07321332. Pfizer will sell the pills it manufactures under the brand name Paxlovid. Medical charity Medecins Sans Frontieres said it was “disheartened” by the deal which it said was restrictive and excluded countries such as Argentina and China with established capacity for producing generic drugs. Advertisement Article content “The world knows by now that access to COVID-19 medical tools needs to be guaranteed for everyone, everywhere, if we really want to control this pandemic,” said Yuanqiong Hu, MSF Senior Legal Policy Adviser. Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, has said the pill cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial. The drug will be used in combination with ritonavir, an HIV drug that is already available generically. Pfizer’s version of the drug will be in high demand. The company has said it expects to manufacture 180,000 treatment courses by the end of next month and at least 50 million courses by the end of 2022. Article content Re. “Would Notley have done a better job than Kenney?” David Staples, Nov. 10 Premier Jason Kenney announced Tuesday that Albertans would be able to begin booking second doses of COVID-19 vaccines beginning Tuesday afternoon. Photo by Chris Schwarz /Government of Alberta David Staples’ worship of Jason Kenney seems to know no bounds. Now he is trying to say Rachel Notley would have not done any better than Jason Kenney in dealing with the pandemic. In his usual way, he cherry-picks his facts. Fascinating that Staples skips over the whole “Best Summer Ever” fiasco. Ms. Notley would not have abandoned all reasonable precautions for the summer to impress rich friends at the Stampede. Ms. Notley would not have gone on holidays and left no one in charge. Ms. Notley would not have lied about being in communication with the office regularly. Ms. Notley would not have stayed out of touch with Albertans for 10 days after returning to Canada. Ms. Notley would not have set up a lottery or a $100 payment to lure the unvaccinated — American-style bribery that is actually a disincentive to vaccination. She would have set up more mobile and culturally sensitive programs that are proven to encourage vaccination. So David Staples, the answer your question: yes, Notley would have done a better job. Charlotte Bragg, Edmonton Edmonton Journal Headline News Sign up to receive daily headline news from the Edmonton Journal, a division of Postmedia Network Inc. Email Address Sign Up By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300 Thanks for signing up! A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Edmonton Journal Headline News will soon be in your inbox. We encountered an issue signing you up. Please try again

Vision Travel Acquisitions

3 Acquisitions

Vision Travel acquired 3 companies. Their latest acquisition was Voyages Cortravco on July 12, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/12/2018

$99M

Acquired

1

4/5/2018

Subscribe to see more

$99M

Subscribe to see more

10

4/11/2017

Debt

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/12/2018

4/5/2018

4/11/2017

Investment Stage

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Vision Travel Partners & Customers

5 Partners and customers

Vision Travel has 5 strategic partners and customers. Vision Travel recently partnered with Uber on February 2, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

2/13/2018

Partner

United States

Uber for Business Announces Alliance With Vision Travel - Vision Travel

Toronto -- Vision Travel , a Direct Travel Company , has become one of the first travel management companies in Canada to form an alliance with Uber .

2

10/24/2017

Partner

Canada

Subscribe to see more

Subscribe to see more

10

5/24/2017

Licensor

Subscribe to see more

Subscribe to see more

10

5/24/2017

Partner

Subscribe to see more

Subscribe to see more

10

4/10/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

2/13/2018

10/24/2017

5/24/2017

5/24/2017

4/10/2017

Type

Partner

Partner

Licensor

Partner

Partner

Business Partner

Country

United States

Canada

United States

News Snippet

Uber for Business Announces Alliance With Vision Travel - Vision Travel

Toronto -- Vision Travel , a Direct Travel Company , has become one of the first travel management companies in Canada to form an alliance with Uber .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Vision Travel Team

1 Team Member

Vision Travel has 1 team member, including former Senior Vice President, David Kruschell.

Name

Work History

Title

Status

David Kruschell

Senior Vice President

Former

Name

David Kruschell

Work History

Title

Senior Vice President

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.